Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genital Herpes01:23

Genital Herpes

Genital herpes is a sexually transmitted infection primarily caused by herpes simplex virus type 2 (HSV-2), though herpes simplex virus type 1 (HSV-1) is increasingly implicated in genital infections, particularly among younger populations. Transmission occurs mainly through sexual contact, with asymptomatic viral shedding serving as a major route of spread. This characteristic makes HSV-2 difficult to control at a population level, as individuals may unknowingly transmit the virus even in the...
Herpes01:28

Herpes

Herpes simplex type 1 (HSV‑1) is a widespread pathogen responsible for orolabial lesions. It is an enveloped, double-stranded DNA (dsDNA) virus belonging to the family Herpesviridae. Once the virus infects a host cell, its double‑stranded DNA genome is delivered into the nucleus, where a coordinated cascade of immediate‑early, early, and late gene expression directs viral DNA replication, structural protein synthesis, and virion assembly. After primary infection of epithelial cells, HSV-1...
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

HbA1c as a Predictor of Complications in Anterior and Posterior Colporrhaphy.

Cureus·2026
Same author

The Impact of a Biopsy Based 17-Gene Genomic Prostate Score on Treatment Recommendations in Men with Newly Diagnosed Clinically Prostate Cancer Who are Candidates for Active Surveillance.

Urology practice·2023
Same author

Use of Monitoring Tests Among Patients With Localized Prostate Cancer Managed With Observation.

The Journal of urology·2023
Same author

Antiadenovirus Antibodies Predict Response Durability to Nadofaragene Firadenovec Therapy in BCG-unresponsive Non-muscle-invasive Bladder Cancer: Secondary Analysis of a Phase 3 Clinical Trial.

European urology·2021
Same author

Optimizing the role of androgen deprivation therapy in advanced prostate cancer: Challenges beyond the guidelines.

The Prostate·2020
Same author

Management Options for Nocturia at a Large Urology Group Practice.

Reviews in urology·2018

Related Experiment Video

Updated: Jun 3, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Human papillomavirus testing in men.

Kathleen F McGinley1, Wayne Hey, David O Sussman

  • 1Delaware Valley Urology, 1605 Evesham Rd, Voorhees, NJ 08043-1437, USA.

The Journal of the American Osteopathic Association
|March 19, 2011
PubMed
Summary
This summary is machine-generated.

Routine human papillomavirus (HPV) screening is not recommended for immunocompetent men. However, high-risk groups like men who have sex with men and HIV-positive men may benefit from HPV screening and anal cytology.

More Related Videos

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Related Experiment Videos

Last Updated: Jun 3, 2026

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Area of Science:

  • Oncology
  • Virology
  • Public Health

Background:

  • Anogenital condylomas and various cancers are linked to human papillomavirus (HPV) infection.
  • Current US guidelines do not recommend routine HPV screening for immunocompetent men.
  • Emerging research highlights high HPV prevalence in specific high-risk populations.

Purpose of the Study:

  • To evaluate the potential benefit of HPV screening in high-risk male populations.
  • To consider the role of anal cytology in HPV detection.
  • To inform screening recommendations for specific male demographics.

Main Methods:

  • Review of emerging research on HPV infection in men.
  • Focus on populations including men who have sex with men (MSM) and HIV-positive men.
  • Consideration of anal cytology and high-resolution anoscopy for follow-up.

Main Results:

  • HPV infection is pervasive and persistent in MSM and HIV-positive men.
  • These populations may experience significant benefits from targeted HPV screening.
  • The study suggests a need for tailored screening approaches.

Conclusions:

  • HPV screening, including anal cytology, should be considered for high-risk men.
  • Screening is recommended in settings with established follow-up protocols, such as high-resolution anoscopy.
  • This approach may help mitigate HPV-related morbidity and mortality in vulnerable populations.